Relevance of plasma level determination of L-Dopa and 3-O-methyldopa in Parkinson's disease - Discussion

被引：0
|
作者：
Przuntek
Horowski
Riederer
Reichmann
Gerlach
Baas
Eichhorn
Kuhn
Schwarz
Henneberg
Ulm
Gehlen
机构：
来源：
AKTUELLE NEUROLOGIE | 1998年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S282 / S285
页数：4
相关论文
共 50 条
  • [1] Relevance of plasma level determination of L-Dopa and 3-O-methyldopa in Parkinson's disease
    Woitalla, D
    AKTUELLE NEUROLOGIE, 1998, 25 : S279 - S281
  • [2] PLASMA 3-O-METHYLDOPA IN L-DOPA THERAPY OF PARKINSONS DISEASE
    MUENTER, MD
    TYCE, GM
    SHARPLESS, NS
    MAYO CLINIC PROCEEDINGS, 1972, 47 (06) : 389 - +
  • [3] 3-O-METHYLDOPA IN L-DOPA THERAPY
    MUENTER, MD
    SHARPLES.NS
    TYCE, GM
    NEUROLOGY, 1972, 22 (04) : 416 - &
  • [4] Deferiprone as Parkinson's disease modifier: quantification of 3-O-methyldopa/l-dopa plasmatic ratio in patients
    Charbonnier-Beaupel, F.
    Bihan, K.
    Zahr, N.
    Corvol, J. C.
    Devos, D.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 73 - 74
  • [5] The role of 3-O-methyldopa in the side effects of L-dopa
    Lee, Eun-Sook Y.
    Chen, Hongtao
    King, Jennifer
    Charlton, Clivel
    NEUROCHEMICAL RESEARCH, 2008, 33 (03) : 401 - 411
  • [6] Determination of L-dopa, carbidopa, 3-O-methyldopa and entacapone in human plasma by HPLC-ED
    Bugamelli, F.
    Marcheselli, C.
    Barba, E.
    Raggi, M. A.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2011, 54 (03) : 562 - 567
  • [7] 3-O-METHYLDOPA, L-DOPA, AND TRIHEXYPHENIDYL IN TREATMENT OF PARKINSONS-DISEASE
    MUENTER, MD
    DINAPOLI, RP
    SHARPLESS, NS
    TYCE, GM
    MAYO CLINIC PROCEEDINGS, 1973, 48 (03) : 173 - 183
  • [8] The Role of 3-O-Methyldopa in the Side Effects of l-dopa
    Eun-Sook Y. Lee
    Hongtao Chen
    Jennifer King
    Clivel Charlton
    Neurochemical Research, 2008, 33 : 401 - 411
  • [9] METHOD FOR DETERMINATION OF DOPA AND 3-O-METHYLDOPA IN PLASMA OF PARKINSONIAN PATIENTS
    CURZON, G
    TRIGWELL, J
    KANTAMAN.BD
    CLINICA CHIMICA ACTA, 1972, 37 (NMAR) : 335 - &
  • [10] 3-METHOXY-4-HYDROXYPHENYLALANINE (3-O-METHYLDOPA) IN PLASMA DURING ORAL L-DOPA THERAPY OF PATIENTS WITH PARKINSONS DISEASE
    SHARPLES.NS
    TYCE, GM
    OWEN, CA
    MUENTER, MD
    CLINICA CHIMICA ACTA, 1972, 37 (NMAR) : 359 - &
12345